The PharmaVOICE Uber Feed: February 2012

White Paper - Understanding Drug-Induced Liver Injury in the Context of Pharmaceutical Development

This whitepaper discusses drug-induced liver injuries within pharmaceutical development.

For more information about PPD, visit http://www.ppdi.com/.

White Paper - Adaptive Social Media in Pharma

This white paper discusses using adaptive social media in the pharmaceutical industry.

For more information about Cognizant, visit http://www.cognizant.com/.

Podcast: Understanding the Impact of Drug Induced Liver Injury on Drug Development

In this episode, Dr. Lobel talks about Drug-induced liver injury, also known as DILI. We'll cover what DILI is, how it is identified, and its effects on the clinical development process. At the end of this podcast, you'll learn where you can download a related white paper on this topic.

For more information about PPD, visit www.ppdi.com.

Podcast: The Evolving Social Media Lifecycle in Pharma

In this episode, a trio of experts from Cognizant talk about numerous issues involving social media in the life sciences. There is also a related white paper you may download.

For more information about Cognizant, visit www.cognizant.com.

White Paper - Transforming R&D Productivity by Re-defining Success in Clinical Trial Enrollment

It may come as a surprise to many pharmaceutical industry experts that the largest portion of an R&D sponsor's investment and the biggest driver of trial budgets is patient enrollment at 32% of trial costs . To those who are already aware of this, it may still be surprising that innovation required to improve this disproportionate budget allocation is already available.

For more information about Acurian, visit http://www.acurian.com/.

Podcast: How the New Role of the CRO Affects Patient Enrollment

In this episode, Dr. Malcolm discusses how the role of the CRO is transitioning from commodity service supplier to strategic partner, and the unintended negative consequences this could have on what is already the most expensive part of clinical trials: patient enrollment.

For more information about Acurian, visit www.acurian.com.

White Paper - ePRO for Late Phase, Post-Approval Market

For ePRO and patients around the world, it's a perfect storm of good news.

For more information about PHT Corp., visit http://www.phtcorp.com/.

Download Whitepaper

See All PharmaVOICE whitepapers

Podcast: Transformative Leadership

In this episode, Dr. Dunsire shares her insights on the quest to find a cure for cancer, on women striving for positions in the C-Suite, and thoughts on her own career development and recognition as the 2009 HBA Woman of the Year.

For more information about Millennium, visit www.millennium.com.

Download Podcast

See All PharmaVOICE podcasts

Thursday, February 2, 2012